BioCentury
ARTICLE | Distillery Therapeutics

Neurology

April 4, 2017 10:01 PM UTC

Cell culture studies identified prodrugs of the PINK1 agonist kinetin riboside triphosphate that could help treat PD. The prodrugs were kinetin riboside phosphorothioate-based compounds that were clea...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article